Drs. Ben Solomon, Leora Horn, & Jack West consider the range of treatment options for patients with an EGFR mutation and acquired resistance that does not harbor a T790M mutation.
Drs. Ben Solomon, Leora Horn, & Jack West consider the range of treatment options for patients with an EGFR mutation and acquired resistance that does not harbor a T790M mutation.
As we learn more about immunotherapy for lung cancer, combinations with multiple immunotherapy agents are being explored. Medical oncologist Dr. Eddie Garon considers whether combinations are likely to emerge as the leading immunotherapy approach.
As we learn more about immunotherapy for lung cancer, combinations with multiple immunotherapy agents are being explored. Medical oncologist Dr. Eddie Garon considers whether combinations are likely to emerge as the leading immunotherapy approach.
Drs. Leora Horn, Ben Solomon, & Jack West consider whether third generation EGFR TKIs, so active in patients with acquired resistance, might be best used prior to development of acquired resistance.
Hi friends – Hoping you all can provide some insight if you can. I really would love those in the know to interpret what some terms mean with...
Dear Moderators and Doctors I’ve read number of exiting articles published by Spanish group about Silibinin, which is extract of milk thistle. Those...
An FDA press release states that: "On August 16, 2018, the Food and Drug Administration granted accelerated approval to nivolumab (Opdivo, Bristol...
Dear Moderators and Doctors I’ve read number of exiting articles published by Spanish group about Silibinin, which is extract of milk thistle. Those...
I was reading the article by Dr West, How long should we continue immune checkpoint inhibitor therapy in patients who respond? This was written in...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.